Financials Human Health Holdings Limited
Equities
1419
KYG4644Q1091
Healthcare Facilities & Services
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1 HKD | 0.00% | +2.04% | -16.67% |
Feb. 27 | Human Health Holdings Limited Reports Earnings Results for the Half Year Ended December 31, 2023 | CI |
Feb. 08 | Human Health Warns of Significant Decline in Fiscal H1 Profit | MT |
Valuation
Fiscal Period: June | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capitalization 1 | 665.2 | 611.1 | 269.5 | 379.6 | 618.7 | 721.1 |
Enterprise Value (EV) 1 | 468.5 | 454.9 | 243.5 | 283.8 | 523.3 | 262.4 |
P/E ratio | 27.6 x | 22.5 x | -6.67 x | 2.63 x | 1.65 x | 3.99 x |
Yield | 1.63% | 1.86% | - | 12% | 18.4% | 8.42% |
Capitalization / Revenue | 1.28 x | 1.16 x | 0.59 x | 0.58 x | 0.55 x | 0.72 x |
EV / Revenue | 0.9 x | 0.86 x | 0.54 x | 0.43 x | 0.47 x | 0.26 x |
EV / EBITDA | 9.65 x | 9.46 x | -30.1 x | 1.82 x | 1.2 x | 0.81 x |
EV / FCF | 14.9 x | 12.2 x | 12.5 x | 18.6 x | 3.6 x | 0.5 x |
FCF Yield | 6.71% | 8.22% | 8.01% | 5.37% | 27.8% | 201% |
Price to Book | 2.43 x | 1.95 x | 1.04 x | 0.93 x | 0.83 x | 0.89 x |
Nbr of stocks (in thousands) | 361,502 | 379,552 | 379,552 | 379,552 | 379,552 | 379,552 |
Reference price 2 | 1.840 | 1.610 | 0.7100 | 1.000 | 1.630 | 1.900 |
Announcement Date | 10/29/18 | 10/29/19 | 10/30/20 | 10/28/21 | 10/28/22 | 10/30/23 |
Income Statement Evolution (Annual data)
Fiscal Period: June | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 518 | 528.6 | 453.7 | 654.7 | 1,122 | 1,002 |
EBITDA 1 | 48.56 | 48.09 | -8.087 | 155.8 | 437.6 | 323.5 |
EBIT 1 | 38.27 | 35.9 | -18.59 | 146.1 | 428.8 | 307.1 |
Operating Margin | 7.39% | 6.79% | -4.1% | 22.31% | 38.23% | 30.65% |
Earnings before Tax (EBT) 1 | 31.79 | 34.72 | -39.01 | 168.8 | 445.3 | 238.8 |
Net income 1 | 24.11 | 26.62 | -40.37 | 144.5 | 375.3 | 180.8 |
Net margin | 4.65% | 5.04% | -8.9% | 22.06% | 33.46% | 18.05% |
EPS 2 | 0.0667 | 0.0717 | -0.1064 | 0.3806 | 0.9888 | 0.4760 |
Free Cash Flow 1 | 31.44 | 37.41 | 19.5 | 15.24 | 145.5 | 528.3 |
FCF margin | 6.07% | 7.08% | 4.3% | 2.33% | 12.97% | 52.74% |
FCF Conversion (EBITDA) | 64.73% | 77.79% | - | 9.78% | 33.25% | 163.32% |
FCF Conversion (Net income) | 130.38% | 140.5% | - | 10.55% | 38.77% | 292.13% |
Dividend per Share 2 | 0.0300 | 0.0300 | - | 0.1200 | 0.3000 | 0.1600 |
Announcement Date | 10/29/18 | 10/29/19 | 10/30/20 | 10/28/21 | 10/28/22 | 10/30/23 |
Balance Sheet Analysis
Fiscal Period: June | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | - | - | - | - | - | - |
Net Cash position 1 | 197 | 156 | 26 | 95.8 | 95.4 | 459 |
Leverage (Debt/EBITDA) | - | - | - | - | - | - |
Free Cash Flow 1 | 31.4 | 37.4 | 19.5 | 15.2 | 146 | 528 |
ROE (net income / shareholders' equity) | 8.73% | 8.96% | -14.1% | 43.2% | 65.2% | 23.3% |
ROA (Net income/ Total Assets) | 7.21% | 5.97% | -2.78% | 17.5% | 30.3% | 15.8% |
Assets 1 | 334.5 | 446.2 | 1,454 | 823.1 | 1,240 | 1,141 |
Book Value Per Share 2 | 0.7600 | 0.8300 | 0.6800 | 1.080 | 1.950 | 2.130 |
Cash Flow per Share 2 | 0.5200 | 0.4200 | 0.3200 | 0.3800 | 0.7100 | 1.690 |
Capex 1 | 9.29 | 8.61 | 11.5 | 14.1 | 76.5 | 84 |
Capex / Sales | 1.79% | 1.63% | 2.53% | 2.15% | 6.82% | 8.39% |
Announcement Date | 10/29/18 | 10/29/19 | 10/30/20 | 10/28/21 | 10/28/22 | 10/30/23 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
-16.67% | 48.48M | |
-14.92% | 84.68B | |
+13.30% | 81.12B | |
+11.62% | 29.4B | |
-12.71% | 16.73B | |
-3.06% | 16.36B | |
-2.63% | 14.92B | |
-31.75% | 11.77B | |
-1.42% | 11.72B | |
+27.44% | 11.71B |
- Stock Market
- Equities
- 1419 Stock
- Financials Human Health Holdings Limited